News

Harvard Quietly Resolves Anti-Palestinian Discrimination Complaint With Ed. Department

News

Following Dining Hall Crowds, Harvard College Won’t Say Whether It Tracked Wintersession Move-Ins

News

Harvard Outsources Program to Identify Descendants of Those Enslaved by University Affiliates, Lays Off Internal Staff

News

Harvard Medical School Cancels Class Session With Gazan Patients, Calling It One-Sided

News

Garber Privately Tells Faculty That Harvard Must Rethink Messaging After GOP Victory

New Treatment Center

By Charles W. Slack

Under the direction of a Medical School surgeon, the Harvard-affiliated Massachusetts General Hospital (MGH) yesterday opened a clinic for treatment of neuro fibromatosis, a genetic nerve disorder which currently afflicts an estimated 100,000 Americans.

Dr. Robert L. Martuza, instructor in surgery, will direct the clinic, the first of its kind in New England. Dr. Martuza was unavailable for comment yesterday.

The ailment, also known as von Recklinghausen's disease, usually begins in childhood and can cause skin polyps, or growths, multiple brain tumors and in some cases, mental retardation.

The Elephant Man

One of the most severe cases on record is that of John Merrick, the subject of the current play and motion picture "The Elephant Man."

Although neuro fibromatosis has no known cure or prevention, patients can be successfully treated, a MGH official said yesterday, adding that the new clinic will facilitate this treatment.

Because the disease is so complicated, patients usually have to move around from one specialist to another--the clinic should eliminate this problem," the official said.

The clinic will offer a number of specialists, including neurologists, dermatologists, psychologists, opthamologists and genetics experts, he said, adding that a backup team of general and plastic surgeons will also be available.

The official said that in addition to offering improved care for patients, the clinic may help doctors in their search for a cure or prevention.

Want to keep up with breaking news? Subscribe to our email newsletter.

Tags